<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Stealth BioTherapeutics Corp.

    Stealth BioTherapeutics Corp.

    We are an innovative biopharmaceutical company developing therapies to treat the m...

    We are an innovative biopharmaceutical company ...

    Filing Type:    PU
    Histogenics Corporation

    Histogenics Corporation

    Histogenics historically focused on the development of restorative cell therapies,...

    Histogenics historically focused on the develop...

    Filing Type:    PU
    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics™ designs, develops, manufactures, and markets proprietary...

    Hypertension Diagnostics™ designs, develops, ma...

    Filing Type:    PU
    IntriCon Corporation

    IntriCon Corporation

    For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...

    For more than 40 years, IntriCon has been meeti...

    Filing Type:    PU
    Alseres Pharmaceuticals

    Alseres Pharmaceuticals

    Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and ther...

    Alseres Pharmaceuticals, Inc. is focused on the...

    Amount Raised:    $5,900,000
    Fundraising Status:    VT
    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    Merit Medical Systems, Inc.

    Merit Medical Systems, Inc.

    Founded in 1987, Merit Medical set out to build the world’s most customer-focuse...

    Founded in 1987, Merit Medical set out to build...

    Filing Type:    PU
    Insulet Corporation

    Insulet Corporation

    Insulet Corporation is an innovative medical device company based in Acton, Massac...

    Insulet Corporation is an innovative medical de...

    Filing Type:    PU
    SI-BONE, Inc.

    SI-BONE, Inc.

    SI-BONE is a medical device company that has pioneered a proprietary minimally inv...

    SI-BONE is a medical device company that has pi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.